IFP Advisors Inc Buys 20,424 Shares of Aspen Aerogels, Inc. (NYSE:ASPN)

IFP Advisors Inc increased its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 6,923.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,719 shares of the construction company’s stock after acquiring an additional 20,424 shares during the period. IFP Advisors Inc’s holdings in Aspen Aerogels were worth $246,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of the stock. Quest Partners LLC lifted its position in Aspen Aerogels by 263.3% in the third quarter. Quest Partners LLC now owns 7,397 shares of the construction company’s stock valued at $205,000 after purchasing an additional 5,361 shares during the last quarter. Mesirow Financial Investment Management Inc. bought a new stake in Aspen Aerogels during the 3rd quarter valued at $252,000. Kovitz Investment Group Partners LLC purchased a new stake in Aspen Aerogels during the 3rd quarter valued at $263,000. Morse Asset Management Inc purchased a new stake in Aspen Aerogels during the 3rd quarter valued at $264,000. Finally, Sigma Planning Corp bought a new stake in Aspen Aerogels in the 3rd quarter worth $274,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on ASPN. Seaport Res Ptn downgraded shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 12th. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday, February 19th. Canaccord Genuity Group cut their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. B. Riley decreased their target price on Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating for the company in a report on Wednesday, February 19th. Finally, Roth Mkm cut their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $22.44.

Aspen Aerogels Stock Up 0.6 %

NYSE:ASPN opened at $7.59 on Monday. Aspen Aerogels, Inc. has a 1-year low of $7.37 and a 1-year high of $33.15. The company has a market capitalization of $622.98 million, a PE ratio of 47.46 and a beta of 2.14. The firm’s 50-day moving average price is $11.16 and its 200-day moving average price is $17.53. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN) last announced its earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, equities analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.